PREgnancy and FERtility Registry
Launched by IRCCS AZIENDA OSPEDALIERA UNIVERSITARIA SAN MARTINO - IST ISTITUTO NAZIONALE PER LA RICERCA SUL CANCRO, GENOA, ITALY · Sep 5, 2016
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The PREgnancy and FERtility Registry (PREFER) is a clinical trial designed to help young women with breast cancer understand and manage issues related to fertility preservation and pregnancy. The study has two main parts: PREFER-FERTILITY, which focuses on gathering information about the choices and experiences of young breast cancer patients regarding fertility preservation options available in Italy; and PREFER-PREGNANCY, which looks at how breast cancer diagnosed during pregnancy is managed, as well as the health of children born after such treatments and the experiences of breast cancer survivors who become pregnant afterward.
To take part in the trial, women must be between 18 and 45 years old, have been diagnosed with breast cancer, and have not yet undergone radiation or chemotherapy for their cancer (for the PREFER-FERTILITY part). Those interested in the PREFER-PREGNANCY part should have been diagnosed with breast cancer during their pregnancy or within a year after giving birth. Participants will share their experiences and outcomes, helping researchers build a better understanding of how to support young women facing these challenges. This information will ultimately help improve care and health outcomes for future patients.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • breast cancer diagnosis
- • age between18 and 45 years (only for PREFER-FERTILITY)
- • have not received any radiation or chemotherapy for cancer before enrolment (only for PREFER-FERTILITY)
- • absence of metastatic disease (only for PREFER-FERTILITY)
- • diagnosis of breast cancer during pregnancy or within 1 year from the end of pregnancy or pregnancy after prior diagnosis and treatment for breast cancer (only for PREFER-PREGNANCY)
- • informed consent
- Exclusion Criteria:
- • inability to provide written informed consent
- • stage IV disease at diagnosis (only for PREFER-FERTILITY)
- • serious psychiatric disorders
About Irccs Azienda Ospedaliera Universitaria San Martino Ist Istituto Nazionale Per La Ricerca Sul Cancro, Genoa, Italy
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, located in Genoa, Italy, is a leading clinical research institution dedicated to advancing oncology through innovative research and high-quality patient care. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it combines hospital services with cutting-edge scientific research, fostering collaboration among clinicians and researchers. The institute focuses on developing novel therapeutic strategies and improving patient outcomes in cancer treatment, making significant contributions to the understanding and management of malignancies. Its commitment to excellence and innovation positions it at the forefront of cancer research in Italy and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lecce, Le, Italy
Asti, , Italy
Perugia, , Italy
Reggio Emilia, , Italy
Cuneo, Cn, Italy
Candiolo, To, Italy
Brindisi, Br, Italy
Monserrato, Cagliari, Italy
Cona, Fe, Italy
Genoa, Ge, Italy
Lido Di Camaiore, Lu, Italy
Mantova, Mn, Italy
Piacenza, Pc, Italy
Pavia, Pv, Italy
Potenza, Pz, Italy
Roma, Rm, Italy
Sassari, Ss, Italy
Udine, Ud, Italy
Negrar, Ve, Italy
Napoli, , Italy
Napoli, , Italy
Pisa, , Italy
Trieste, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials